triamcinolone acetonide
Generic: triamcinolone acetonide
Labeler: padagis israel pharmaceuticals ltdDrug Facts
Product Profile
Brand Name
triamcinolone acetonide
Generic Name
triamcinolone acetonide
Labeler
padagis israel pharmaceuticals ltd
Dosage Form
OINTMENT
Routes
Active Ingredients
triamcinolone acetonide .5 mg/g
Manufacturer
Identifiers & Regulatory
Product NDC
45802-817
Product ID
45802-817_a43dca71-a425-4ce0-a84d-d2586b77a978
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA212460
Listing Expiration
2026-12-31
Marketing Start
2021-03-01
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
45802817
Hyphenated Format
45802-817
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
triamcinolone acetonide (source: ndc)
Generic Name
triamcinolone acetonide (source: ndc)
Application Number
ANDA212460 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .5 mg/g
Packaging
- 430 g in 1 JAR (45802-817-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["TOPICAL"], "spl_id": "a43dca71-a425-4ce0-a84d-d2586b77a978", "openfda": {"nui": ["N0000175576", "N0000175450"], "upc": ["0345802817013"], "unii": ["F446C597KA"], "rxcui": ["1090641"], "spl_set_id": ["3cb47c24-b7eb-4709-8a41-cbeceadbc8d9"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "430 g in 1 JAR (45802-817-01)", "package_ndc": "45802-817-01", "marketing_start_date": "20210301"}], "brand_name": "triamcinolone acetonide", "product_id": "45802-817_a43dca71-a425-4ce0-a84d-d2586b77a978", "dosage_form": "OINTMENT", "pharm_class": ["Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]"], "product_ndc": "45802-817", "generic_name": "triamcinolone acetonide", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "triamcinolone acetonide", "active_ingredients": [{"name": "TRIAMCINOLONE ACETONIDE", "strength": ".5 mg/g"}], "application_number": "ANDA212460", "marketing_category": "ANDA", "marketing_start_date": "20210301", "listing_expiration_date": "20261231"}